WVE Q3 2022 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$285,000-99.2% YoY

Gross Profit

-$27M-9575.4% margin

Operating Income

-$39M-13648.8% margin

Net Income

-$39M-13685.6% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

-24.0%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$182M

Total Liabilities

$178M

Stockholders' Equity

$3M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$285,000	$36M	-99.2%
Gross Profit	-$27M	$5M	-611.3%
Operating Income	-$39M	-$8M	-411.4%
Net Income	-$39M	-$6M	-526.1%